METHYLPREDNISOLONE ACETATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for methylprednisolone acetate and what is the scope of patent protection?
Methylprednisolone acetate
is the generic ingredient in six branded drugs marketed by Pharmacia And Upjohn, Pfizer, Bel Mar, Amneal, Endo Operations, Epic Pharma Llc, Eugia Pharma, Hong Kong, Sagent Pharms Inc, Sandoz, Slayback Pharma Llc, Teva Pharms Usa, and Watson Labs, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.There are ten drug master file entries for methylprednisolone acetate. Eleven suppliers are listed for this compound.
Summary for METHYLPREDNISOLONE ACETATE
US Patents: | 0 |
Tradenames: | 6 |
Applicants: | 13 |
NDAs: | 23 |
Drug Master File Entries: | 10 |
Finished Product Suppliers / Packagers: | 11 |
Raw Ingredient (Bulk) Api Vendors: | 46 |
Clinical Trials: | 38 |
Patent Applications: | 6,980 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for METHYLPREDNISOLONE ACETATE |
What excipients (inactive ingredients) are in METHYLPREDNISOLONE ACETATE? | METHYLPREDNISOLONE ACETATE excipients list |
DailyMed Link: | METHYLPREDNISOLONE ACETATE at DailyMed |
Recent Clinical Trials for METHYLPREDNISOLONE ACETATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Menoufia University | N/A |
Centre hospitalier de l'Université de Montréal (CHUM) | Phase 4 |
Yale University | Phase 2 |